IRIS
CATTANEO, DARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.375
SA - Sud America 2.077
NA - Nord America 1.701
EU - Europa 476
Continente sconosciuto - Info sul continente non disponibili 307
AF - Africa 116
OC - Oceania 2
Totale 8.054
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 1.635
US - Stati Uniti d'America 1.535
SG - Singapore 1.521
VN - Vietnam 1.165
CN - Cina 282
IT - Italia 278
AR - Argentina 199
ID - Indonesia 93
EC - Ecuador 84
BD - Bangladesh 74
MX - Messico 60
HK - Hong Kong 54
CA - Canada 51
ZA - Sudafrica 46
CO - Colombia 44
RU - Federazione Russa 41
PY - Paraguay 39
IQ - Iraq 37
IN - India 33
CL - Cile 28
UA - Ucraina 23
GB - Regno Unito 19
VE - Venezuela 19
JM - Giamaica 18
DE - Germania 15
FR - Francia 15
PE - Perù 15
MA - Marocco 14
PK - Pakistan 14
EG - Egitto 12
UZ - Uzbekistan 12
DZ - Algeria 10
PL - Polonia 10
KE - Kenya 9
SA - Arabia Saudita 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
ES - Italia 8
PH - Filippine 8
AL - Albania 7
IE - Irlanda 7
MY - Malesia 7
TR - Turchia 7
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
JP - Giappone 6
NP - Nepal 6
SN - Senegal 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
FI - Finlandia 5
GT - Guatemala 5
HN - Honduras 5
KZ - Kazakistan 5
SE - Svezia 5
SI - Slovenia 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
IL - Israele 4
JO - Giordania 4
LB - Libano 4
AT - Austria 3
BG - Bulgaria 3
CR - Costa Rica 3
KW - Kuwait 3
NL - Olanda 3
OM - Oman 3
PA - Panama 3
AU - Australia 2
BE - Belgio 2
BW - Botswana 2
BY - Bielorussia 2
CH - Svizzera 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
NG - Nigeria 2
NI - Nicaragua 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GP - Guadalupe 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 7.737
Salva come PNG Salva come JPEG
Città #
Ho Chi Minh City 434
Ashburn 350
Singapore 302
Hanoi 238
Dallas 184
San Jose 176
São Paulo 124
Beijing 104
Milan 85
Rio de Janeiro 57
Santa Clara 52
Da Nang 51
Hong Kong 50
Rome 43
Los Angeles 41
Haiphong 39
Biên Hòa 37
Curitiba 33
Hải Dương 33
Assago 30
Brasília 29
Guayaquil 28
New York 26
Porto Alegre 26
Thái Bình 26
Belo Horizonte 23
Quito 22
Ninh Bình 21
Salvador 21
Campinas 20
Johannesburg 20
Guarulhos 19
Ribeirão Preto 19
Buenos Aires 17
Can Tho 17
Fortaleza 17
Mexico City 16
Philadelphia 15
Santo André 15
Sorocaba 15
Chicago 14
Jakarta 14
Manaus 14
Thái Nguyên 14
Bogotá 13
Buffalo 13
Houston 13
Bắc Giang 12
Phủ Lý 12
Resistencia 12
Wilmington 12
Baghdad 11
Cape Town 11
Goiânia 11
Montreal 11
Santiago 11
São Gonçalo 11
Turin 11
Viamão 11
Asunción 10
Austin 10
Belém 10
Caxias do Sul 10
Ha Long 10
Kingston 10
Lấp Vò 10
Naples 10
Orem 10
Princeton 10
Richmond 10
Tashkent 10
Warsaw 10
Cao Lanh 9
Cotia 9
Dhaka 9
Medellín 9
Newark 9
Piracicaba 9
Shanghai 9
Caracas 8
Clear Fork 8
Figino 8
Franca 8
Hortolândia 8
Juiz de Fora 8
Mauá 8
Pelotas 8
Quảng Ngãi 8
Saint Paul 8
Sherwood 8
Sumaré 8
Bandung 7
Brooklyn 7
Cairo 7
Carapicuíba 7
Charlotte 7
Dublin 7
Florence 7
Guarujá 7
Huế 7
Totale 3.458
Salva come PNG Salva come JPEG
Nome #
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma. 83
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial 71
"CATCH" Study: Correct Antibiotic Therapy in Continuous Hemofiltration in the Critically Ill in Continuous Renal Replacement Therapy: A Prospective Observational Study 47
Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects 44
Acute kidney injury in a preterm infant homozygous for the C3435T polymorphism in the ABCB1 gene given oral morphine 41
Appropriateness of loading dose and TDM in patients treated with teicoplanin: a single-centre observational retrospective cohort study comparing single-daily and thrice-weekly regimens 40
Are non-serious adverse reactions to psychiatric drugs really non-serious ? 40
ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment 40
Neonatal Outcomes of Newborns Exposed to SSRI during Pregancy: a Pharmacokinetic and Pharmacogenetic Analysis 40
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantation 39
Antibiotic Therapy Strategies for Treating Gram- Negative Severe Infections in the Critically Ill: A Narrative Review. 38
Pharmacogenomics of immunosuppressive agents: perspective for individualized therapy 38
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy 38
Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients 37
Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients 37
Loss of Control of HIV Viremia With OTC Weight-Loss Drugs: A Call for Caution? 36
Potential association between rosuvastatin use and high atazanavir trough concentrations in ritonavir-treated HIV-infected patients 36
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 36
Application Of Quality By Design Approach To Bioanalysis: Development Of A Method For Elvitegravir Quantification In Human Plasma 36
A three-in-one, long-acting, nanosuspension reformulation of off-patent antiretrovirals for low-income and middle-income countries 35
Pharmacokinetics of mycophenolate sodium and comparison with the mofetil transplant recipients formulation in stable kidney 35
Lights and shadows of the actual European guidelines on bioanalytical method validation : the case of raltegravir 35
Simultaneous determination of everolimus and cyclosporine concentrations by HPLC with ultraviolet detection 34
Population Pharmacokinetics of Mycophenolic Acid A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients 34
Liver Injury After Dietary Supplements in Patients Living With HIV: A Call to Action 34
How to fully protect the kidney in a severe model of progressive nephropathy: A multidrug approach 34
ACE inhibitors and ribavirin-associated cough: a common undefined predisposing factor? 34
Analytical performance specifications for measurement uncertainty in therapeutic monitoring of immunosuppressive drugs 33
Drug-induced liver steatosis in patients with HIV infection 33
Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients 33
Increased levetiracetam clearance and breakthrough seizure in a pregnant patient successfully handled by intensive therapeutic drug monitoring 33
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 33
Effect of combining ACE inhibitor and statin in severe experimental nephropathy 33
Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report 33
Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience 33
Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure 33
A Comparison of Tenofovir Predose Concentrations in Generic Pre-exposure Prophylaxis Formulations: A Short Communication 33
Psychoactive drugs and HIV: are we sure to treat our patients adequately? 33
Serotonin reuptake inhibitors in pregnancy : can genes help us in predicting neonatal adverse outcome? 33
Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review 33
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients 33
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy 33
Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV 33
Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience 33
Cyclosporine formulation and Kaposi's sarcoma after renal transplantation 33
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 32
Preventing COVID-19 in assisted living facilities: An impossible task pending vaccination roll out 32
Therapeutic Drug Monitoring of Antibiotics in the Elderly: A Narrative Review 32
Aldosterone and progression of kidney disease 32
Ameliorating Hypertension and Insulin Resistance in Subjects at Increased Cardiovascular Risk Effects of Acetyl-L-Carnitine Therapy 32
Two-hour blood cyclosporine level does not necessarily predict drug exposure and graft function outcome in stable kidney transplant recipients 32
Pharmacovigilance knowledge in family paediatricians. A survey study in Italy 32
Therapeutic drug monitoring of sirolimus: Effect of concomitant immunosuppressive therapy and optimization of drug dosing 32
Practices of therapeutic drug monitoring in tuberculosis: an international survey. 32
Management of Polypharmacy and Potential Drug–Drug Interactions in Patients with Mycobacterial Infection: A 1-Year Experience of a Multidisciplinary Outpatient Clinic 32
Optimizing Antibiotic Therapy for Intravenous Drug Users: A Narrative Review Unraveling Pharmacokinetics/Pharmacodynamics Challenges 32
Drug-Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients 31
Assessment of sirolimus concentrations in whole blood by high-performance liquid chromatography with ultraviolet detection 31
Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics 31
Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma 31
[Functional loss of the transplanted kidney: immunological and non-immunological factors]. FT La perdita di funzione del rene trapiantato: fattori immunologici e non-immunologici 31
Perceptions and patterns of use of generic drugs among Italian family pediatricians : first round results of a web survey 31
Comparison of different cyclosporine immunoassays to monitor C-0 and C-2 blood levels from kidney transplant recipients: Not simply overestimation 31
Safety and efficacy of non-standard posology of paracetamol to manage pain in pediatric patients 31
In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: Insights from the MYSS Trial 31
Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes A prospective randomized double-blind clinical trial 31
Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients 31
Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once 30
Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients : a Call for Action? 30
Risks of potential drug–drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience 30
Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation 30
Effects of ursodeoxycholic acid on rilpivirine plasma trough concentrations: a case report 30
Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review. 30
Development and validation of a chromatographic ultraviolet method for the simultaneous quantification of dolutegravir and rilpivirine in human plasma 30
Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor-Free Regimen 30
No effects of nirmatrelvir/ritonavir on darunavir plasma trough concentrations: a case report 30
Delayed graft function in kidney transplantation 30
Multidrug-resistant HIV viral rebound during early syphilis: a case report 30
Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies : evidence from Phase I studies in healthy volunteers 30
Non-operative management of uncomplicated appendicitis in children, why not? A meta-analysis of randomized controlled trials 30
Why do echinocandins fail? Identifying key predictors to improve clinical outcomes of candida bloodstream infections: a retrospective multicenter cohort study 30
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions 29
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies : evidence from a safety study with pilot efficacy measures in adult dystrophic patients 29
From pharmacokinetics to pharmacogenomics: A new approach to tailor immunosuppressive therapy 29
Chemotherapy, targeted therapy and immunotherapy: Which drugs can be safely used in the solid organ transplant recipients? 29
Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detection 29
Linezolid-related haematological toxicity in a peritoneal dialysis patient: the role of therapeutic drug monitoring 29
Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections 29
Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing 29
Pregnancy-related changes of antiretroviral pharmacokinetics: an argument for TDM 29
Optimizing antibiotic therapy for intravenous drug users: a narrative review unraveling pharmacokinetics/pharmacodynamics challenges 29
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis 29
Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients 29
Application of Quality by Design Approach to Bioanalysis: Development of a Method for Elvitegravir Quantification in Human Plasma 29
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies 29
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation 29
Drug-drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment 29
Drug-Drug Interactions Between Antiretrovirals and Carbamazepine/Oxcarbazepine: A Real-Life Investigation 29
Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts 29
Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics? 29
Totale 3.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.194
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.194
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 2 0 0 1 1 1 1 3 4
2022/202319 5 0 3 3 1 1 0 1 1 2 2 0
2023/202414 2 2 3 0 0 0 3 1 0 0 1 2
2024/202517 1 0 0 0 0 3 0 1 2 7 0 3
2025/20267.316 311 480 1.055 2.351 529 180 791 515 387 321 185 211
2026/2027650 605 45 0 0 0 0 0 0 0 0 0 0
Totale 8.054